Eli Lilly: Stellar Q1 Earnings Put Pharma In Class Of Its Own, It's Ok To Buy Today (LLY)

Lilly posts another ‘blowout quarter’ as focus turns to Foundayo launch

Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554

Eli Lilly Q1 2026 Earnings Call Transcript

Not just GLP-1: Peptide-drug conjugate hits 5 obesity targets

FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies

Why is Eli Lilly stock surging today?

Eli Lilly smashes Q1 forecasts as Mounjaro, Zepbound demand soars

Crohn’s Disease Market: Accelerating Growth and Pipeline Impact by 2034 – DelveInsight | Merck, Eli Lilly and Company, RedHill Biopharma, Bristol Myers Squibb, Dr. Falk Pharma GmbH, Janssen-Cilag Ltd

Lilly CEO says Foundayo launch will be "just fine" (LLY:NYSE)

Eli Lilly's 'Blowout' Quarter: Here's What Has 'Overwhelming' Demand

Eli Lilly and Company (LLY.US) 1Q26 Profit Surges 1.7x YoY to USD7.4B, Beats; Raises FY Guidance; Shares Up 6% Pre-Mkt

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

Eli Lilly and Company Reports Earnings Results for the First Quarter Ended March 31, 2026

Lilly clocks 56% revenue increase in Q1 but declining prices stunt growth

Eli Lilly (LLY) Is Down 7.6% After Upbeat Q1 And Foundayo Approval - What's Changed

Eli Lilly Shares Jump On Guidance Boost, Earnings Above Expectations

Eli Lilly (Q1 2026 earnings: revenue jumps 56% to $19.8B

Lilly CEO shades amylin rivals AbbVie, Pfizer in cutthroat battle for obesity’s next act

Earnings Flash (LLY) Eli Lilly and Company Reports Q1 Revenue $19.80B, vs. FactSet Est of $17.82B